A PRISMA systematic review found that while individual terpenes in cannabis show exploratory therapeutic benefits, the hypothesis that terpenes synergistically enhance cannabinoid effects remains unproven in clinical evidence.
Cannabis consumers evaluating whole-plant vs. isolate products, medical cannabis patients, cannabis industry researchers
Entourage effect remains unproven
What the researchers found
Analysis found no evidence of neuroprotective or anti-aggregatory effects of pinene against beta-amyloid toxicity, though modest lipid peroxidation inhibition was observed. Myrcene showed topical anti-inflammatory properties but did not add significant benefit when combined with CBD. The entourage effect remains unproven.
Why it matters
The entourage effect is heavily marketed in the cannabis industry to justify whole-plant products over isolated cannabinoids. This systematic review found the evidence does not yet support those marketing claims.
The numbers in context
Terpenes studied: alpha-pinene, beta-pinene, terpinolene, myrcene, linalool, D-limonene, caryophyllene, valencene, borneol, eucalyptol. No significant additive benefit of myrcene when combined with CBD.
How the study worked
PRISMA systematic review searching PubMed/MEDLINE, Web of Science, and EBSCO databases using MeSH terms, examining two questions: physiological effects of cannabis terpenes and proven entourage effects.
What this study cannot tell us
Limited number of high-quality clinical trials testing specific terpene-cannabinoid combinations. Most evidence is preclinical or exploratory. The entourage effect may require specific combinations or conditions not yet tested.
How to read the evidence
PRISMA systematic review with structured methodology, but limited by the small number of clinical trials testing the entourage hypothesis.
When this study was published
2024 PRISMA systematic review of entourage effect evidence
The bigger picture
The gap between entourage effect marketing and scientific evidence is significant. While individual terpenes may have therapeutic properties on their own, the synergistic enhancement of cannabinoids that the entourage hypothesis predicts has not been demonstrated in rigorous studies.
Questions still open
- Could specific terpene-cannabinoid ratios produce synergistic effects not captured in current studies? Are certain terpenes more likely to interact with cannabinoids than others?
Common questions
What is the entourage effect?
Does this mean whole-plant cannabis products are no better than isolates?
Read the original research
The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review.
Pharmaceuticals (Basel, Switzerland), 17(11)
Citation
André, Rebeca; Gomes, Ana Patrícia; Pereira-Leite, Catarina; Marques-da-Costa, António; Monteiro Rodrigues, Luis; Sassano, Michael; Rijo, Patricia; Costa, Maria do Céu. (2024). The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review.. Pharmaceuticals (Basel, Switzerland), 17(11). https://doi.org/10.3390/ph17111543
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk